MARKER THERAPEUTICS INC's ticker is MRKR and the CUSIP is 57055L107. A total of 67 filers reported holding MARKER THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.18 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $7,807 | +11.8% | 21,170 | 0.0% | 0.00% | – |
| Q2 2022 | $6,986 | -25.0% | 21,170 | 0.0% | 0.00% | – |
| Q1 2022 | $9,315 | -53.7% | 21,170 | 0.0% | 0.00% | -100.0% |
| Q4 2021 | $20,116 | -37.9% | 21,170 | +10.4% | 0.00% | 0.0% |
| Q3 2021 | $32,397 | +33.9% | 19,170 | +121.1% | 0.00% | 0.0% |
| Q2 2021 | $24,189 | +24.6% | 8,670 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $19,421 | +86.8% | 8,670 | +20.9% | 0.00% | 0.0% |
| Q4 2020 | $10,397 | +141.5% | 7,170 | +149.8% | 0.00% | – |
| Q3 2020 | $4,305 | -38.3% | 2,870 | -14.8% | 0.00% | – |
| Q2 2020 | $6,976 | +15.8% | 3,370 | +6.3% | 0.00% | -100.0% |
| Q1 2020 | $6,023 | -34.0% | 3,170 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $9,130 | -53.8% | 3,170 | -18.1% | 0.00% | -50.0% |
| Q3 2019 | $19,776 | -41.5% | 3,870 | -9.4% | 0.00% | -33.3% |
| Q2 2019 | $33,818 | +109.1% | 4,270 | +74.3% | 0.00% | +50.0% |
| Q1 2019 | $16,170 | – | 2,450 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 3,142,857 | $2,986,000 | 1.05% |
| ACT CAPITAL MANAGEMENT, LLC | 354,400 | $337,000 | 0.24% |
| NEA Management Company, LLC | 10,714,285 | $10,179,000 | 0.21% |
| Long Focus Capital Management, LLC | 1,233,257 | $1,172,000 | 0.16% |
| Mandatum Life Insurance Co Ltd | 99,000 | $94,000 | 0.02% |
| MATRIX ASSET ADVISORS INC/NY | 150,000 | $143,000 | 0.02% |
| AR ASSET MANAGEMENT INC | 71,500 | $68,000 | 0.02% |
| KENNEDY CAPITAL MANAGEMENT LLC | 590,118 | $561,000 | 0.01% |
| WealthTrust Axiom LLC | 22,700 | $21,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 324,216 | $308,000 | 0.01% |